JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB168379

Anti-PDHA1 antibody [EPR11098]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

Be the first to review this product! Submit a review

|

(45 Publications)

Anti-PDHA1 antibody [EPR11098] (ab168379) is a rabbit monoclonal antibody detecting PDHA1 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications

View Alternative Names

PHE1A, PDHA1, PDHE1-A type I

20 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling PDHA1 with unpurified ab168379 at 1/100 dilution. Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunocytochemistry/ Immunofluorescence analysis of HT-29 (Human colorectal adenocarcinoma epithelial cell) cells labeling PDHA1 with Purified ab168379 at 1 : 100 dilution (3.5 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG (Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunofluorescent analysis of HepG2 cells labeling PDHA1 with unpurified ab168379 at 1/100 dilution.

Flow Cytometry (Intracellular) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Intracellular Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling PDHA1 with purified ab168379 at 1/40 dilution (10 ug/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilized with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling PDHA1 with unpurified ab168379 at 1/100 dilution. Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunocytochemistry/Immunofluorescence analysis Jurkat (human acute T cell leukemia) labelling PDHA1 with purified ab168379 at 1/500. Cells were fixed with 100% methanol. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (ab150077). Nuclei counterstained with DAPI (blue).

Control : PBS only

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human thyroid carcinoma tissue sections labeling PDHA1 with Purified ab168379 at 1 : 200 dilution (1.76 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH 9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.

Flow Cytometry (Intracellular) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Intracellular flow cytometric analysis of permeabilized Jurkat cells labeling PDHA1 (red) with unpurified ab168379 at 1/10 dilution, or a rabbit IgG (negative) (green).

Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IP

Lab

Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (AB168379)

ab168379 (purified) at 1 : 20 dilution (2ug) immunoprecipitating PDHA1 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 (+) : ab168379 & HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab168379 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (ab168379)

Predicted band size: 43 kDa

false

Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IP

Unknown

Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (AB168379)

Detection of PDHA1 by Western Blot of Immunprecipitate. 293T cell lysate immunoprecipitated using unpurified ab168379 at 1/10 dilution; HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.

All lanes:

Immunoprecipitation - Anti-PDHA1 antibody [EPR11098] (ab168379)

Predicted band size: 43 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat kidney tissue sections labeling PDHA1 with Purified ab168379 at 1 : 200 dilution (1.76 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH 9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDHA1 antibody [EPR11098] (AB168379)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse kidney tissue sections labeling PDHA1 with Purified ab168379 at 1 : 200 dilution (1.76 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH 9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Supplier Data

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, Anti-PDHA1 antibody [EPR11098] - (ab168379) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-PDHA1 (phospho S232) antibody [EPR29825-102] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s232-antibody-epr29825-102-ab325169'>ab325169</a>) at 1/1000 dilution

Lane 1:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (Lambda Protein Phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 43 kDa

false

Exposure time: 26s

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Lab

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Lanes 1 - 3 : Merged signal (red and green). Green - ab168379 observed at 43 kDa. Red - loading control, ab130007, observed at 130 kDa.

ab168379 was shown to recognize PDHA1 in wild-type A549 cells as signal was lost at the expected MW in PDHA1 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and PDHA1 knockout samples were subjected to SDS-PAGE. ab168379 and ab130007 (Mouse anti Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PDHA1 antibody [EPR11098] (ab168379) at 1/1000 dilution

Lane 1:

Wild-type A549 whole cell lysate at 20 µg

Lane 2:

PDHA1 knockout A549 whole cell lysate at 20 µg

Lane 2:

Western blot - Human PDHA1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-pdha1-knockout-a549-cell-line-ab261866'>ab261866</a>)

Lane 3:

HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg

Predicted band size: 43 kDa

Observed band size: 43 kDa

false

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Supplier Data

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The identity of the band higher than 250 kDa is unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-PDHA1 antibody (ab168379) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-PDHA1 (phospho S300) antibody [EPR29824-87] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s300-antibody-epr29824-87-ab324265'>ab324265</a>) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

HeLa treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg

Lane 3:

Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg

Lane 4:

NIH/3T3 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg

Lane 5:

Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Lane 6:

HeLa treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Lane 7:

Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Lane 8:

NIH/3T3 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 43 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Supplier Data

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Performed under reducing conditions.

In Western blot, ab325169 was shown to bind specifically to PDHA1. Target of interest was observed at 43 kDa in induced wild-type A549 cell lysates (lane 2) with no signal observed at this size in induced PDHA1 knockout cell line (lane 4).

Lanes 1-4 on the left untreated membrane with Lambda Protein Phosphatase; Lanes 1-4 on the right treated membrane with Lambda Protein Phosphatase.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-PDHA1 antibody [EPR11098] - (ab168379) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-PDHA1 (phospho S232) antibody [EPR29825-102] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s232-antibody-epr29825-102-ab325169'>ab325169</a>) at 1/1000 dilution

Lane 1:

Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

A549 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate at 20 µg

Lane 3:

Untreated PDHA1 knockout A549 whole cell lysate at 20 µg

Lane 4:

PDHA1 knockout A549 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 43 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Lab

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-PDHA1 antibody [EPR11098] (ab168379) at 1/2000 dilution

Lane 1:

HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 20 µg

Lane 2:

Mouse brain lysates at 20 µg

Lane 3:

Rat brain lysates at 20 µg

Lane 4:

Mouse kidney lysates at 20 µg

Lane 5:

Rat kidney lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 43 kDa

false

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Supplier Data

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Performed under reducing conditions.

In Western blot, ab324265 was shown to bind specifically toPDHA1 (phospho S300). Target of interest was observed at 43 kDa in Wild-type A549 treated with 100ng/ml Calyculin A (lane 2), with no signal observed at this size in PDHA1 knockout cell line (lanes 3-4).

The identity of the band higher than 250 kDa is unknown.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-PDHA1 antibody (ab168379) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-PDHA1 (phospho S300) antibody [EPR29824-87] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s300-antibody-epr29824-87-ab324265'>ab324265</a>) at 1/1000 dilution

Lane 1:

Untreated Wild-type A549 (human lung carcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

Wild-type A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg

Lane 3:

Untreated PDHA1 knockout A549 whole cell lysate (untreated membrane) at 20 µg

Lane 4:

PDHA1 knockout A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (untreated membrane) at 20 µg

Lane 5:

Untreated Wild-type A549 (human lung carcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Lane 6:

Wild-type A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Lane 7:

Untreated PDHA1 knockout A549 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Lane 8:

PDHA1 knockout A549 treated with 100ng/ml Calyculin A for 30 min whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 43 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Supplier Data

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, Anti-PDHA1 antibody [EPR11098] - (ab168379) staining at 1/1000 dilution.

All lanes:

Western blot - Anti-PDHA1 (phospho S232) antibody [EPR29825-102] (<a href='/en-us/products/primary-antibodies/pdha1-phospho-s232-antibody-epr29825-102-ab325169'>ab325169</a>) at 1/1000 dilution

Lane 1:

Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg

Lane 2:

NIH/3T3 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate (untreated membrane) at 20 µg

Lane 3:

NIH/3T3 treated with 100ng/ml Calyculin A for 30 minutes whole cell lysate (Lambda Protein Phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 43 kDa

false

Exposure time: 10s

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)
  • WB

Unknown

Western blot - Anti-PDHA1 antibody [EPR11098] (AB168379)

All lanes:

Western blot - Anti-PDHA1 antibody [EPR11098] (ab168379) at 1/1000 dilution

Lane 1:

Human fetal kidney lysate at 10 µg

Lane 2:

A549 lysate at 10 µg

Lane 3:

Jurkat lysate at 10 µg

Lane 4:

HepG2 lysate at 10 µg

Lane 5:

HeLa lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 43 kDa

false

  • Carrier free

    Anti-PDHA1 antibody [EPR11098] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-PDHA1 antibody [EPR11098]

  • HRP

    HRP Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]

  • 578 PE

    PE Anti-Pyruvate Dehydrogenase E1-alpha subunit antibody [EPR11098]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR11098

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

Flow Cyt (Intra), IP, IHC-P, ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/10 - 1/100", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-PDHA1 antibody [EPR11098] (ab168379) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of PDHA1?
Anti-PDHA1 [EPR11098] (ab168379) specifically detects a band for PDHA1 (UniProt: P08559) at a molecular weight of 43kDa.

Trusted by the scientific community
Anti-PDHA1 [EPR11098] (ab168379) was first used in a scientific publication in 2013 and has been cited over 30 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-PDHA1 antibody [EPR11098] (ab168379) has been confirmed by Western blot testing in PDHA1 Knockout HeLa cells.

Other related products
We have a range of other formats of antibody clone [EPR11098] also available for your convenience: ab168379, Carrier free - ab176835, PE - ab305779, HRP - ab305781, Alkaline Phosphatase - ab308723, Alexa Fluor® 488 - ab309686, Alexa Fluor® 647 - ab310050, Alexa Fluor® 594 - ab310440, Alexa Fluor® 555 - ab311968, Alexa Fluor® 750 - ab321159

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PDHA1 also known as the pyruvate dehydrogenase E1 alpha subunit plays a mechanical role in cellular metabolism. It forms part of the larger pyruvate dehydrogenase (PDH) complex where it serves as a critical catalytic component. PDHA1 is expressed ubiquitously across different tissue types reflecting its fundamental function in energy production. The molecular weight of the PDHA1 protein is approximately 43 kDa. Alternate names for this protein include the PDH E1 component and it partners closely with other components in the PDH complex to facilitate its role.
Biological function summary

PDHA1 engages in the conversion of pyruvate into acetyl-CoA an important step in cellular respiration. This protein is part of the PDH complex which consists of multiple copies of three catalytic and two regulatory subunits. The conversion process is essential for linking glycolysis to the citric acid cycle efficiently channeling energy substrates within the cell. Furthermore the functional activity of PDHA1 is regulated through phosphorylation by the pyruvate dehydrogenase kinases (PDKs) and dephosphorylation by PDH phosphatases.

Pathways

PDHA1 is integral to the metabolic pathway of cellular respiration and energy production. It enables the transition between glycolysis and the citric acid cycle by facilitating the conversion of pyruvate to acetyl-CoA which enters the citric acid cycle. Related proteins in this pathway include PDHA2 and the regulatory PDKs that modulate PDHA1 activity. These interactions ensure energy metabolism adapts to various cellular conditions influencing energy balance and substrate utilization.

Mutations or dysfunctions in PDHA1 can lead to disorders such as pyruvate dehydrogenase deficiency and Leigh syndrome. These conditions result from impaired energy metabolism leading to severe neurological symptoms and overall energy deficits in tissues with high metabolic demands. The link between PDHA1 and diseases highlights the importance of maintaining its function. Additionally altered interaction with proteins involved in phosphorylation such as the PDKs can exacerbate pathogenic conditions by further disbalancing metabolic activities.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Together with PDHB forms the heterotetrameric E1 subunit of the pyruvate dehydrogenase (PDH) complex (PubMed : 17474719, PubMed : 19081061). The PDH complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links cytoplasmic glycolysis and the mitochondrial tricarboxylic acid (TCA) cycle (PubMed : 19081061, PubMed : 7782287). It contains multiple copies of three enzymatic components : pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and dihydrolipoamide dehydrogenase (E3) (Probable). The E1 subunit catalyzes both the thiamine pyrophosphate (TPP)-dependent decarboxylation of pyruvate and the reductive acetylation of a lipoyl group covalently linked to the lipoyl-bearing domains of E2 (PubMed : 17474719, PubMed : 19081061, PubMed : 7782287).
See full target information PDHA1

Publications (45)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:3177 PubMed40180922

2025

Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation.

Applications

Unspecified application

Species

Unspecified reactive species

Ning Zhang,Linmao Sun,Shuo Zhou,Changyong Ji,Tianming Cui,Qi Chu,Jiareng Ye,Shuhang Liang,Kun Ma,Yufeng Liu,Xianying Li,Xinyu Guo,Weizhi Zhang,Xuetian Gu,Cheng Cheng,Qingrui Zha,Shengwei Tao,Yunguang Zhang,Junhui Chu,Chenghui Wu,Yuchen Zhang,Jiabei Wang,Yao Liu,Lianxin Liu

British journal of pharmacology 182:2409-2425 PubMed39933533

2025

Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin-induced cardiotoxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Jiajia Wei,Guozhen Lan,Wenfang Zhang,Wang Ran,Yu Wei,Xin Liu,Yuandong Zhang,Qihai Gong,Haibo Li,Jianmei Gao

JACS Au 5:302-319 PubMed39886595

2025

SMAP3-ID for Identification of Endogenous Protein-Protein Interactions Reveals Regulation of Mitochondrial Activity by Lamins.

Applications

Unspecified application

Species

Unspecified reactive species

Julia Warren,Jian Wang,Francis Dhoro,Bo Chao,Ashok Reddy,Stefanie Kaech Petrie,Larry L David,Xiangshu Xiao,Bingbing X Li

Nature metabolism 7:212-227 PubMed39809975

2025

Multiplex genome editing eliminates lactate production without impacting growth rate in mammalian cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hooman Hefzi,Iván Martínez-Monge,Igor Marin de Mas,Nicholas Luke Cowie,Alejandro Gomez Toledo,Soo Min Noh,Karen Julie la Cour Karottki,Marianne Decker,Johnny Arnsdorf,Jose Manuel Camacho-Zaragoza,Stefan Kol,Sanne Schoffelen,Nuša Pristovšek,Anders Holmgaard Hansen,Antonio A Miguez,Sara Petersen Bjørn,Karen Kathrine Brøndum,Elham Maria Javidi,Kristian Lund Jensen,Laura Stangl,Emanuel Kreidl,Thomas Beuchert Kallehauge,Daniel Ley,Patrice Ménard,Helle Munck Petersen,Zulfiya Sukhova,Anton Bauer,Emilio Casanova,Niall Barron,Johan Malmström,Lars K Nielsen,Gyun Min Lee,Helene Faustrup Kildegaard,Bjørn G Voldborg,Nathan E Lewis

International journal of molecular sciences 26: PubMed39796278

2025

Glutaminase-2 Expression Induces Metabolic Changes and Regulates Pyruvate Dehydrogenase Activity in Glioblastoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Juan De Los Santos-Jiménez,José A Campos-Sandoval,Tracy Rosales,Bookyung Ko,Francisco J Alonso,Javier Márquez,Ralph J DeBerardinis,José M Matés

NPJ precision oncology 8:258 PubMed39521913

2024

RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Jierong Chen,Zi-Yue Li,Guansheng Zheng,Lixue Cao,Yun-Miao Guo,Qizhou Lian,Bing Gu,Cai-Feng Yue

Pharmacological research 207:107336 PubMed39094987

2024

Inhibition of K63 ubiquitination by G-Protein pathway suppressor 2 (GPS2) regulates mitochondria-associated translation.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Gao,Julian Kwan,Joseph Orofino,Giulia Burrone,Sahana Mitra,Ting-Yu Fan,Justin English,Ryan Hekman,Andrew Emili,Shawn M Lyons,Maria Dafne Cardamone,Valentina Perissi

FEBS open bio 14:1441-1454 PubMed38952051

2024

Extracellular glucose triggers metabolic reprogramming of cultured human bronchial epithelial cells and indirect fibroblast activation.

Applications

Unspecified application

Species

Unspecified reactive species

Sangmi S Park,Rafael Ward,Patrick Geraghty,Itsaso Garcia-Arcos

Biomaterials research 28:0035 PubMed38840655

2024

Plant-Derived Exosomes as Novel Nanotherapeutics Contrive Glycolysis Reprogramming-Mediated Angiogenesis for Diabetic Ulcer Healing.

Applications

Unspecified application

Species

Unspecified reactive species

Minhong Tan,Yuda Liu,Yang Xu,Ge Yan,Nan Zhou,Haoran Chen,Zhihong Jiang,Lihua Peng

Cell metabolism 36:1394-1410.e12 PubMed38838644

2024

Imaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiency.

Applications

Unspecified application

Species

Unspecified reactive species

Isaac Marin-Valencia,Arif Kocabas,Carlos Rodriguez-Navas,Vesselin Z Miloushev,Manuel González-Rodríguez,Hannah Lees,Kelly E Henry,Jake Vaynshteyn,Valerie Longo,Kofi Deh,Roozbeh Eskandari,Arsen Mamakhanyan,Marjan Berishaj,Kayvan R Keshari
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com